Skip to main content

Volume 19 - Issue 5 - May, 2007

Feature

Case Report
08/01/2008
Coronary artery fistulae are extremely rare1 and can either be congenital or acquired secondary to cardiac intervention or surgery. They have also been reported following acute myocardial infarction.2 The majority of these fistulae arise from...
Coronary artery fistulae are extremely rare1 and can either be congenital or acquired secondary to cardiac intervention or surgery. They have also been reported following acute myocardial infarction.2 The majority of these fistulae arise from...
Coronary artery fistulae are...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Prof. Dr. Sigrid Nikol MD: I welcome you to this session, New Developments in Gene Therapy and Stem Cells for Angiogenesis in the Treatment of Myocardial Infarction. Initial developments of regenerative therapies were mainly angiogenesis...
Prof. Dr. Sigrid Nikol MD: I welcome you to this session, New Developments in Gene Therapy and Stem Cells for Angiogenesis in the Treatment of Myocardial Infarction. Initial developments of regenerative therapies were mainly angiogenesis...
Prof. Dr. Sigrid Nikol MD: I...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Robert Simari, MD: I appreciate this opportunity to present some general insights into the fields of gene and cell therapy, both from a perspective as an experimental biologist, as a clinician as well as from a regulatory perspective to see...
Robert Simari, MD: I appreciate this opportunity to present some general insights into the fields of gene and cell therapy, both from a perspective as an experimental biologist, as a clinician as well as from a regulatory perspective to see...
Robert Simari, MD: I appreciate...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Treatment of patients with hypertrophic obstructive cardiomyopathy (HOCM) and refractory symptoms remains a challenge.1 Surgical septal myectomy remains the classical approach for these patients.2 This therapy is associated with good initial...
Treatment of patients with hypertrophic obstructive cardiomyopathy (HOCM) and refractory symptoms remains a challenge.1 Surgical septal myectomy remains the classical approach for these patients.2 This therapy is associated with good initial...
Treatment of patients with...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Despite extensive advances in cardiology over the past 50 years, the definitive treatment for aortic stenosis remains unchanged. Aortic valve replacement, while employing enhanced prostheses, continues as an imperfect therapy with inherent...
Despite extensive advances in cardiology over the past 50 years, the definitive treatment for aortic stenosis remains unchanged. Aortic valve replacement, while employing enhanced prostheses, continues as an imperfect therapy with inherent...
Despite extensive advances in...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Only two therapies for acute stroke intervention have been approved by the U.S. Food and Drug Administration: intravenous tissue plasminogen activator (tPA) and the Merci retriever (Concentric Medical, Mountainview, California). Many patients...
Only two therapies for acute stroke intervention have been approved by the U.S. Food and Drug Administration: intravenous tissue plasminogen activator (tPA) and the Merci retriever (Concentric Medical, Mountainview, California). Many patients...
Only two therapies for acute...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Coronary artery fistula (CAF) is a rare congenital cardiac anomaly in which a communication is present between a coronary artery and either a cardiac chamber or another vascular structure. It accounts for 0.2–0.45% of all congenital cardiac...
Coronary artery fistula (CAF) is a rare congenital cardiac anomaly in which a communication is present between a coronary artery and either a cardiac chamber or another vascular structure. It accounts for 0.2–0.45% of all congenital cardiac...
Coronary artery fistula (CAF) is...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Biventricular pacing (BVP) for the treatment of congestive heart failure is now one of the forefront therapies for heart failure patients who continue to have symptoms despite maximal medical therapy. Recent advances in lead technology and...
Biventricular pacing (BVP) for the treatment of congestive heart failure is now one of the forefront therapies for heart failure patients who continue to have symptoms despite maximal medical therapy. Recent advances in lead technology and...
Biventricular pacing (BVP) for...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Congenitally corrected transposition of the great vessels (CCTGA) is a rare congenital heart defect (CHD) and constitutes less than 1% of all congenital heart disease. The two fundamental anatomic abnormalities in CCTGA consist of...
Congenitally corrected transposition of the great vessels (CCTGA) is a rare congenital heart defect (CHD) and constitutes less than 1% of all congenital heart disease. The two fundamental anatomic abnormalities in CCTGA consist of...
Congenitally corrected...
08/01/2008
Journal of Invasive Cardiology

Column

Editorial Message
08/01/2008
Dear Readers,The May 2007 issue of the Journal of Invasive Cardiology includes original research articles, commentaries, a review article, clinical images, online case reports, and a continuation of discussions from the Biennial Andreas...
Dear Readers,The May 2007 issue of the Journal of Invasive Cardiology includes original research articles, commentaries, a review article, clinical images, online case reports, and a continuation of discussions from the Biennial Andreas...
Dear Readers,The May 2007 issue...
08/01/2008
Journal of Invasive Cardiology